CAS RN: 196618-13-0
Oseltamivir
Product Availability
Choose a grade to view its available package options.
4 package records 4 with current stock 1 grade group
Grade
97% (4)
In stock only
Batch No. Package Availability Warehouse Inquiry
Batchno.20250905
100mg
In stock
Shenzhen Inquiry
Batchno.20250912
1g
In stock
Shanghai, Tianjin, Wuhan, Chengdu Inquiry
Batchno.20250416
250mg
In stock
Tianjin, Chengdu Inquiry
Batchno.20250222
5g
In stock
Tianjin, Wuhan, Chengdu Inquiry
Product code:
ICTO0591
Purity/Analytical Methods:
>98.0%(T)(HPLC)
GET A QUOTE
196618-13-0 / ethyl (3R,4R,5S)-4-acetamido-5-amino-3-pentan-3-yloxycyclohexene-1-carboxylate
Standard CAS: 196618-13-0
Multi CAS: No
Basic Information
copy
CAS
196618-13-0 copy
Multi CAS
No copy
Molecular Formula
C16H28N2O4 copy
Molecular Weight
312.400000 copy
Exact Mass
312.204907 copy
SMILES
CCC(CC)O[C@@H]1C=C(C[C@@H]([C@H]1NC(=O)C)N)C(=O)OCC copy
InChI
InChI=1S/C16H28N2O4/c1-5-12(6-2)22-14-9-11(16(20)21-7-3)8-13(17)15(14)18-10(4)19/h9,12-15H,5-8,17H2,1-4H3,(H,18,19)/t13-,14+,15+/m0/s1 copy
InChIKey
VSZGPKBBMSAYNT-RRFJBIMHSA-N copy
Physical Properties
copy
Physical Description
Solid copy
State
Solid copy
Storage Conditions
Store dry powder at 25 °C (77 °F); excursions permitted to 15 deg to 30 °C (59 deg to 86 °F).
Store the capsules at 25 °C (77 °F); excursions permitted to 15 deg to 30 °C (59 deg to 86 °F). copy
Computed Properties
copy
Structural Parameters
Heavy atom count
22 copy
Fraction Csp3
0.75 copy
Rotatable bonds
7 copy
H-bond acceptors
5 copy
H-bond donors
2 copy
Molar refractivity
84.16 copy
TPSA
90.65 copy
LogP / Solubility
WLOGP
1.29 copy
MLOGP
1.14 copy
XLogP3
1.1 copy
Consensus LogP
1.18 copy
Log S (ESOL)
-2.12 copy
Class (ESOL)
Moderately soluble copy
Log S (Ali)
-3.05 copy
Class (Ali)
Poorly soluble copy
Log S (SILICOS-IT)
-3.6 copy
Class (SILICOS-IT)
Poorly soluble copy
ADME
GI absorption
High copy
BBB permeant
No copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
Yes copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-3.71 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
Yes copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Leadlikeness
Yes copy
Synthetic Accessibility
4 copy